{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:08:17Z","timestamp":1790698097650,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.adro.2021.100838","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T22:48:20Z","timestamp":1635461300000},"page":"100838","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study"],"prefix":"10.1016","volume":"7","author":[{"given":"Elie","family":"Barakat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andras","family":"Bibok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Rishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altan","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica M.","family":"Frakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Hoffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avan J.","family":"Armaghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixa E.","family":"Soyano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo L.B.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghassan","family":"El-Haddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8898-650X","authenticated-orcid":false,"given":"Bela","family":"Kis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2021.100838_bib0001","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.adro.2021.100838_bib0002","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.adro.2021.100838_bib0003","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/jnci\/djn233","article-title":"Residual risk of breast cancer recurrence 5 years after adjuvant therapy","volume":"100","author":"Brewster","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.adro.2021.100838_bib0004","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/014107689108401207","article-title":"Breast liver metastases\u2014incidence, diagnosis and outcome","volume":"84","author":"Hoe","year":"1991","journal-title":"J R Soc Med"},{"key":"10.1016\/j.adro.2021.100838_bib0005","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1200\/JCO.1987.5.5.773","article-title":"Clinical course of breast cancer patients with liver metastases","volume":"5","author":"Zinser","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2021.100838_bib0006","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","article-title":"Breast cancer metastasis: Markers and models","volume":"5","author":"Weigelt","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.adro.2021.100838_bib0007","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1016\/j.ejca.2011.06.024","article-title":"Hepatic resection for metastatic breast cancer: A systematic review","volume":"47","author":"Chua","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2021.100838_bib0008","first-page":"524","article-title":"Hepatic resection for noncolorectal nonendocrine liver metastases","volume":"244","author":"Adam","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.adro.2021.100838_bib0009","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1245\/s10434-010-0931-5","article-title":"Liver resection for multimodal treatment of breast cancer metastases: Identification of prognostic factors","volume":"17","author":"Hoffmann","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2021.100838_bib0010","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0040-1720949","article-title":"Hepatic metastasis from breast cancer","volume":"37","author":"Liberchuk","year":"2020","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.adro.2021.100838_bib0011","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10549-017-4228-2","article-title":"Ablative therapies in metastatic breast cancer: A systematic review","volume":"164","author":"Kucharczyk","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.adro.2021.100838_bib0012","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1631\/jzus.B1700516","article-title":"Radiofrequency ablation versus hepatic resection for breast cancer liver metastasis: A systematic review and meta-analysis","volume":"19","author":"Xiao","year":"2018","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.adro.2021.100838_bib0013","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.jvir.2019.12.013","article-title":"Predictors of survival after yttrium-90 radioembolization of chemotherapy-refractory hepatic metastases from breast cancer","volume":"31","author":"Davisson","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.adro.2021.100838_bib0014","doi-asserted-by":"crossref","DOI":"10.1177\/1073274817729244","article-title":"Liver-directed therapies for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"24","author":"Kis","year":"2017","journal-title":"Cancer Control"},{"key":"10.1016\/j.adro.2021.100838_bib0015","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ijrobp.2007.03.056","article-title":"Use of yttrium-90 microspheres in the treatment of unresectable hepatic metastases from breast cancer","volume":"69","author":"Coldwell","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2021.100838_bib0016","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jvir.2007.02.019","article-title":"90Y radioembolization of metastatic breast cancer to the liver: Toxicity, imaging response, survival","volume":"18","author":"Bangash","year":"2007","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.adro.2021.100838_bib0017","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jvir.2008.07.009","article-title":"Salvage radioembolization of liver-dominant metastases with a resin-based microsphere: Initial outcomes","volume":"19","author":"Stuart","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.adro.2021.100838_bib0018","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jvir.2008.01.009","article-title":"Radioembolization in patients with hepatic metastases from breast cancer","volume":"19","author":"Jakobs","year":"2008","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.adro.2021.100838_bib0019","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2967\/jnumed.111.096230","article-title":"18F-FDG PET\/CT predicts survival after radioembolization of hepatic metastases from breast cancer","volume":"53","author":"Haug","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.adro.2021.100838_bib0020","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s00330-012-2556-5","article-title":"Radioembolisation with (90)Y-labelled resin microspheres in the treatment of liver metastasis from breast cancer","volume":"23","author":"Cianni","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.adro.2021.100838_bib0021","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1245\/s10434-013-3436-1","article-title":"Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: A large single-center experience of 40 patients","volume":"21","author":"Saxena","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.adro.2021.100838_bib0022","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jvir.2014.07.007","article-title":"Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy","volume":"25","author":"Gordon","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.adro.2021.100838_bib0023","first-page":"421","article-title":"Total lesion glycolysis and sequential (90)Y-selective internal radiation therapy in breast cancer liver metastases: Preliminary results","volume":"30","author":"Bagni","year":"2015","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1016\/j.adro.2021.100838_bib0024","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2967\/jnumed.115.165050","article-title":"Safety, efficacy, and prognostic factors after radioembolization of hepatic metastases from breast cancer: A large single-center experience in 81 patients","volume":"57","author":"Fendler","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/j.adro.2021.100838_bib0025","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jvir.2016.05.028","article-title":"Yttrium-90 radioembolization of advanced, unresectable breast cancer liver metastases\u2014a single-center experience","volume":"27","author":"Pieper","year":"2016","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.adro.2021.100838_bib0026","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/j.jvir.2018.04.018","article-title":"Association of PI3K pathway mutations with early PET\/CT imaging response after radioembolization for breast cancer liver metastases: Results of a single center retrospective pilot study","volume":"29","author":"Deipolyi","year":"2018","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.adro.2021.100838_bib0027","first-page":"3063","article-title":"Liver-dominant breast cancer metastasis: A comparative outcomes study of chemoembolization versus radioembolization","volume":"38","author":"Chang","year":"2018","journal-title":"Anticancer Res"},{"key":"10.1016\/j.adro.2021.100838_bib0028","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1007\/s00270-019-02375-7","article-title":"PET\/CT imaging characteristics after radioembolization of hepatic metastasis from breast cancer","volume":"43","author":"Deipolyi","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.adro.2021.100838_bib0029","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MNM.0000000000001345","article-title":"Yttrium-90 dosimetry and implications on tumour response and survival after radioembolisation of chemo-refractory hepatic metastases from breast cancer","volume":"42","author":"Cheng","year":"2021","journal-title":"Nucl Med Commun"},{"key":"10.1016\/j.adro.2021.100838_bib0030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4251\/wjgo.v12.i2.228","article-title":"Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: A systematic review","volume":"12","author":"Feretis","year":"2020","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.adro.2021.100838_bib0031","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jvir.2010.10.029","article-title":"Research reporting standards for radioembolization of hepatic malignancies","volume":"22","author":"Salem","year":"2011","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.adro.2021.100838_bib0032","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijrobp.2006.11.060","article-title":"Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium","volume":"68","author":"Kennedy","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2021.100838_bib0033","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.adro.2021.100838_bib0034","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10549-019-05254-4","article-title":"Intra-arterial mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: Safety, efficacy and factors influencing survival","volume":"176","author":"Aarts","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.adro.2021.100838_bib0035","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.3748\/wjg.v11.i24.3782","article-title":"Treatment for liver metastases from breast cancer: Results and prognostic factors","volume":"11","author":"Li","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.adro.2021.100838_bib0036","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.cgh.2013.04.028","article-title":"Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization","volume":"11","author":"Salem","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.adro.2021.100838_bib0037","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1148\/rg.2019180095","article-title":"Expected and unexpected imaging findings after 90Y transarterial radioembolization for liver tumors","volume":"39","author":"Spina","year":"2019","journal-title":"Radiographics"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109421001962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452109421001962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:41:06Z","timestamp":1762530066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452109421001962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2452109421001962"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2021.100838","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transarterial Yttrium-90 Glass Microsphere Radioembolization of Chemotherapy-Refractory Breast Cancer Liver Metastases: Results of a Single Institution Retrospective Study","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2021.100838","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100838"}}